Veradermics Prices Upsized IPO at $17, Targeting $256.3 Million in Gross Proceeds
Veradermics, Incorporated has set the price for its upsized initial public offering at $17.00 per share for 15,077,647 shares, anticipating approximately $256.3 million in gross proceeds before fees. The dermatologist-founded company aims to begin trading on the New York Stock Exchange under the ticker MANE in early February 2026, and has provided …